Clinical Trial Update: Effect of Empagliflozin on Podocyte Specific Proteins in African American Veterans With NDKD [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating the effect of empagliflozin on podocyte-specific proteins in African American veterans with non-diabetic kidney disease is cur…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Kidney Disease
• Non-diabetic Kidney Disease

Drugs mentioned

• Empagliflozin (empagliflozin)

Snippet

Sponsor: Washington D.C. Veterans Affairs Medical Center | Conditions: Chronic Kidney Diseases | Phase 4 | Status: RECRUITING